URGN
UroGen Pharma Ltd.
$26.39+0.29 (+1.11%)Close Nov 12, 2026
May 4, 2017 – Nov 12, 2026, Dividends reinvested
- Final balance
- $18,877
- CAGR
- +6.90%
- Max drawdown
- −93.98%
- Sharpe ratio
- 0.45
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
URGN's average annual return was 6.65% over the last 5 years, through Nov 12, 2026. $10,000 in URGN on Nov 12, 2021 grew to $13,795 by Nov 12, 2026, with dividends reinvested.
Total
- 1M
- −31.06%
- 3M
- −46.14%
- 6M
- −11.44%
- YTD
- +12.68%
- 1Y
- +4.97%
Per year
- 3Y
- +32.05%
- 5Y
- +6.65%
- Since 2017
- +6.90%
Annual returns
2017 from May 4 · 2026 through Nov 12
URGN returns by year
| Year | Return |
|---|---|
| 2026 through Nov 12 | +12.68% |
| 2025 | +119.91% |
| 2024 | −29.00% |
| 2023 | +69.11% |
| 2022 | −6.73% |
| 2021 | −47.23% |
| 2020 | −46.00% |
| 2019 | −22.50% |
| 2018 | +15.72% |
| 2017 from May 4 | +166.17% |
Metrics
Since 2017| Volatility | 78.69% |
|---|---|
| Sortino ratio | 0.76 |
| Calmar ratio | 0.07 |
| Best year, 2025 | +119.91% |
| Worst year, 2021 | −47.23% |
| Positive years | 3 of 8 |
| Longest drawdown | 8.5 years |
Worst drawdowns
Since 2017| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −94.0% | May 2018 | May 2025 | Not yet | 8.5 years so far |
| −20.1% | May 2017 | Jun 2017 | Jun 2017 | 4 weeks |
| −18.5% | Jan 2018 | Feb 2018 | Mar 2018 | 1 month |
| −16.6% | Sep 2017 | Oct 2017 | Nov 2017 | 2 months |
| −16.0% | Mar 2018 | Apr 2018 | Apr 2018 | 3 weeks |